QuidelOrtho Corporation
QDEL · NASDAQ
12/29/2024 | 12/31/2023 | 1/1/2023 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 4.80 | -0.21 | -0.62 |
| FCF Yield | -3.79% | 1.44% | 15.30% | 9.03% |
| EV / EBITDA | -3.79 | 12.22 | 6.79 | 5.25 |
| Quality | ||||
| ROIC | -32.56% | 0.61% | 7.78% | 33.47% |
| Gross Margin | 46.23% | 49.85% | 59.28% | 75.26% |
| Cash Conversion Ratio | -0.04 | -27.74 | 1.61 | 1.14 |
| Growth | ||||
| Revenue 3-Year CAGR | -5.20% | 20.85% | 25.26% | 46.99% |
| Free Cash Flow Growth | -258.11% | -90.48% | 45.07% | -9.15% |
| Safety | ||||
| Net Debt / EBITDA | -1.77 | 4.11 | 2.34 | -0.69 |
| Interest Coverage | -10.41 | 0.78 | 11.15 | 1,294.38 |
| Efficiency | ||||
| Inventory Turnover | 2.80 | 2.60 | 2.54 | 2.15 |
| Cash Conversion Cycle | 129.37 | 128.17 | 131.62 | 167.67 |